Rodman & Renshaw is out with its report today on Dendreon DNDN, maintaining Market Outperform.
In its report, Rodman & Renshaw writes, "We are reiterating our Market Outperform rating for Dendreon and maintaining our price target of $17 based on
a discounted 2015 EPS and revenues valuation analysis. The bottom-line is that significant uncertainty exists in the near-term."
At the time of posting, shares of DNDN were trading at $11.09, up 1.93% from Thursday's close.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in